Skip to main content

Rehmann Capital Advisory Group

Position in PFE — Pfizer Inc

CIK 1633037 LANSING, MI

Position in PFE

as of Jun 30, 2026 · filed Aug 20, 2026
Position Value
$3,661,749
-$870,447 QoQ
Shares Held
152,066
-5.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#729
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. PFE ranks #4 (9.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 PFE
Pfizer Inc
This page
152,066 $3,661,749

All Filings in PFE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,661,749 152,066
2026-03-31 $4,532,196 161,403
2025-12-31 $4,018,785 161,397
2025-09-30 $4,421,417 173,525
2025-06-30 $3,997,224 164,902
2025-03-31 $3,932,945 155,207
2024-12-31 $4,380,766 165,125
2024-09-30 $4,905,127 169,493
2024-06-30 $4,741,602 169,464
2024-03-31 $3,817,872 137,581
2023-12-31 $3,850,057 133,729
2023-09-30 $4,091,287 123,343
2023-06-30 $4,741,036 129,254
2023-03-31 $4,510,480 110,551
2022-12-31 $5,677,801 110,808
2022-09-30 $4,885,541 111,644
2022-06-30 $5,897,536 112,484
2022-03-31 $5,860,571 113,204
2021-12-31 $7,079,032 119,882
2021-09-30 $5,333,110 123,997
2021-06-30 $4,716,587 120,444
2021-03-31 $4,335,716 119,672
2020-12-31 $4,439,617 120,609
2020-09-30 $4,365,790 118,959
2020-06-30 $4,317,352 132,029
2020-03-31 $3,984,294 122,068